Atherogenic lipoprotein particles can vary considerably in their cholesterol content, but each particle contains only one molecule of apoB-100 (or simply apoB). As a result, serum concentration of ...

Managed care initiatives to reduce cardiovascular disease (CVD) risk have, to date, focused almost exclusively on statins, which are primarily low-density lipoprotein cholesterol-lowering agents and ...

Expert Rev Cardiovasc Ther. 2008;6(3):391-409. Phosphatidic acid phosphatase/phosphohydrolase (PAP) is an enzyme that catalyzes the conversion of phosphatidic acid to ...

What happens when this doctor goes keto and his LDL rockets to 574? We dive deep into the science, controversy, and personal decision-making behind the most misunderstood lipid profile in cardiology.

Multiple plasma lipoprotein particles and metabolic markers are associated with risks of MI and ischemic stroke, a new analysis shows. With the aid of nuclear magnetic resonance spectroscopy, ...

Patients with hyperlipidemia treated with evolocumab had a greater reduction in atherogenic lipoprotein particles compared with those who received placebo, according to a post hoc subanalysis ...

In honor of September being National Cholesterol Education Month, Johns Hopkins is highlighting several resources available to university employees to prevent and control high cholesterol. The article ...

A recent study published in the Virology Journal has highlighted the significance of high-density lipoprotein (HDL) in coronavirus disease 2019 (COVID-19) pathogenesis and outcome. A severely low ...

The third guidelines from the of the National Cholesterol Education Program’s (NCEP) Adult Treatment Panel (ATP III) have always placed an emphasis on therapeutic lifestyle changes (TLC) as an ...